SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Wednesday reported a loss of $1.3 million in its first quarter.
On a per-share basis, the San Clemente, California-based company said it had a loss of 4 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The glaucoma treatments developer posted revenue of $54 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $50.1 million.
Glaukos expects full-year revenue in the range of $225 million to $230 million.
Glaukos shares have risen 31% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $73.65, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS